4
Changes in Ownership
Benitec Biopharma Inc. Filed Acc 0001062993-22-023660
Options or other derivatives
- Director acquired 12,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Smith Edward F Director | 2022-12-07 | Grant or award · Options (right to buy) | +12,000 | 12,000 | D | ||
Loading xslF345X03/form4.xml…